Position
Renaissance Technologies in Belite Bio, Inc
Back to the book · All holders of BLTE
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$283.7K$159.44 → $153.99
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q1 2026 | 52K | $8.29M | — | — | — | 0.0% |
| Q2 2026 | 55.8K | $8.59M | $153.99 | −$283.7K | $579.4K | 0.0% |